Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Fighting the Pandemic with Collaboration at Heart: Report from Cardiologists in a COVID-19 Dedicated Portuguese Intensive Care Unit
Session:
Posters - K. Cardiovascular Disease In Special Populations
Speaker:
Pedro Ribeiro Queirós
Congress:
CPC 2021
Topic:
K. Cardiovascular Disease In Special Populations
Theme:
30. Cardiovascular Disease in Special Populations
Subtheme:
30.14 Cardiovascular Disease in Special Populations - Other
Session Type:
Posters
FP Number:
---
Authors:
Pedro Ribeiro Queirós; Daniel Caeiro; Marta Ponte; Cláudio Guerreiro; Marisa Silva; Sara Pipa; Ana Lúcia Rios; Diana Adrião; Raúl Neto; Diogo Ferreira; Fábio Sousa Nunes; Gualter Silva; Mariana Brandão; Mariana Ribeiro Da Silva; Rafael Teixeira; Nuno Dias Ferreira; Paula Castelões; Pedro Braga
Abstract
<p><span style="font-family:Arial,serif"><span style="font-size:medium"><strong>Introduction and Objectives:</strong></span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> The </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">coronavirus disease 2019 (COVID-19)</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> spread quickly around the world. Although mainly a respiratory illness, there is growing interest in non-respiratory manifestations, particularly cardiovascular ones. At our centre, mobilization of cardiologists with intensive care training was needed. Our aim is to describe the patients with severe COVID-19 admitted in a Portuguese ICU, the cardiovascular impact of the disease and the experience of cardiologists working in a COVID-19 ICU</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">.</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium"><strong>Methods:</strong></span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> Data from a</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">dult patients </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">with COVID-19 </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">admitted to the hospital </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">between 16</span></span><sup><span style="font-family:Arial,serif"><span style="font-size:medium">th</span></span></sup><sup><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span></sup><span style="font-family:Arial,serif"><span style="font-size:medium">March 2020 and 21</span></span><sup><span style="font-family:Arial,serif"><span style="font-size:medium">st</span></span></sup><sup><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span></sup><span style="font-family:Arial,serif"><span style="font-size:medium">April 2020 w</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">ere</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> retrospectively analysed.</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium"><strong>Results: </strong></span></span><span style="font-family:Arial,serif"><span style="font-size:medium">Thirty-five</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> patients were admitted. Mean age was 62.6±6.0 years and 23 (65.7%) were male.</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">Dyslipidaemia was the most common cardiovascular risk factor (65.7%,n=23), followed by hypertension (57.1%,n=20).</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">Mean ICU stay time was 15.9±10.0 days.</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> Patients had h</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">igh rates of mechanical ventilation (88.6%,n=31) and vasopressor support (88.6%,n=31). Low rates of new onset</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> left systolic dysfunction</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> were detected</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> (</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">8.5%</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">,</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">n=2).</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> O</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">ne</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> patient</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">required veno-arterial extra-corporeal membrane oxygenation</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">. Mortality rate was 25% (n=9). Acute myocardial injury</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> and </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">N-terminal pro brain natriuretic peptide (NT-proBNP)</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> elevation </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">was detected in 62.9% (n=22).</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> Patients that died had higher NT-proBNP compared to those discharged alive (p</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"><0.05</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">). Care by cardiologists frequently changed decision making. </span></span><span style="font-family:Arial,serif"><span style="font-size:medium"><strong>Conclusions:</strong></span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">The cardiovascular impact of COVID-19 </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">seems relevant but </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">is </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">still widely unknown. </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">S</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">tudies are needed to clarify the role of cardiac markers in COVID-19</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> prognosis</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">. </span></span><span style="font-family:Arial,serif"><span style="font-size:medium">M</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">ultidisciplinary care most likely result</span></span><span style="font-family:Arial,serif"><span style="font-size:medium">s</span></span><span style="font-family:Arial,serif"><span style="font-size:medium"> in improved patient care.</span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site